These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34771610)

  • 1. The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment.
    Iorio M; Umesh Ganesh N; De Luise M; Porcelli AM; Gasparre G; Kurelac I
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.
    Gupta S; Roy A; Dwarakanath BS
    Front Oncol; 2017; 7():68. PubMed ID: 28447025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
    Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
    Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target.
    Ocaña MC; Martínez-Poveda B; Quesada AR; Medina MÁ
    Med Res Rev; 2019 Jan; 39(1):70-113. PubMed ID: 29785785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.
    Wegiel B; Vuerich M; Daneshmandi S; Seth P
    Front Oncol; 2018; 8():284. PubMed ID: 30151352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment.
    Zerbib E; Arif T; Shteinfer-Kuzmine A; Chalifa-Caspi V; Shoshan-Barmatz V
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Gaßler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches.
    Navarro C; Ortega Á; Santeliz R; Garrido B; Chacín M; Galban N; Vera I; De Sanctis JB; Bermúdez V
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities.
    Zhao X; Li K; Chen M; Liu L
    Biomed Pharmacother; 2023 Jun; 162():114601. PubMed ID: 36989719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment.
    Benito-Lopez JJ; Marroquin-Muciño M; Perez-Medina M; Chavez-Dominguez R; Aguilar-Cazares D; Galicia-Velasco M; Lopez-Gonzalez JS
    Front Oncol; 2022; 12():1101503. PubMed ID: 36713558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.
    van Genugten EAJ; Weijers JAM; Heskamp S; Kneilling M; van den Heuvel MM; Piet B; Bussink J; Hendriks LEL; Aarntzen EHJG
    Front Oncol; 2021; 11():786089. PubMed ID: 35070990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
    Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
    Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic crosstalk in the breast cancer microenvironment.
    Dias AS; Almeida CR; Helguero LA; Duarte IF
    Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metabolic cancer therapy on tumor microenvironment.
    Hyroššová P; Milošević M; Škoda J; Vachtenheim J; Rohlena J; Rohlenová K
    Front Oncol; 2022; 12():1046630. PubMed ID: 36582801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the microenvironment in solid tumors.
    Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
    Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microbiome - an integral part of the tumor microenvironment.
    Ciernikova S; Sevcikova A; Stevurkova V; Mego M
    Front Oncol; 2022; 12():1063100. PubMed ID: 36505811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Plasticity of Stem Cells and Macrophages in Cancer.
    Krstic J; Trivanovic D; Jaukovic A; Santibanez JF; Bugarski D
    Front Immunol; 2017; 8():939. PubMed ID: 28848547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.